Laurie H Sehn Selected Research

Prednisone (Sone)

1/2022	Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
1/2022	Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
1/2021	End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.
1/2021	Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.
1/2021	Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
1/2020	A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA.
1/2019	Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
1/2019	Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
12/2017	Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.
11/2017	Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurie H Sehn Research Topics

Disease

53	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022 - 08/2005
27	Neoplasms (Cancer) 11/2021 - 06/2007
24	Lymphoma (Lymphomas) 01/2022 - 04/2005
18	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 09/2011
14	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 05/2007
8	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 08/2010
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 03/2012
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 03/2009
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2014
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 05/2012
3	Disease Progression 05/2019 - 06/2015
3	Neutropenia 01/2018 - 06/2015
2	Febrile Neutropenia 01/2018 - 06/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2017 - 06/2013
1	Infections 01/2022
1	COVID-19 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Residual Neoplasm 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Hypoalbuminemia 12/2017
1	Erythema elevatum diutinum 01/2017
1	Thrombocytopenia (Thrombopenia) 08/2016
1	Cough 10/2015
1	Hepatitis C 05/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2014

Drug/Important Bio-Agent (IBA)

61	Rituximab (Mabthera)FDA Link 01/2022 - 08/2005
31	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2005
29	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 08/2005
29	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2005
28	Prednisone (Sone)FDA LinkGeneric 01/2022 - 08/2005
13	obinutuzumabIBA 10/2021 - 05/2012
7	Bendamustine Hydrochloride FDA Link 01/2022 - 08/2016
7	Biological ProductsIBA 01/2022 - 10/2006
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2011
6	Proteins (Proteins, Gene)FDA Link 12/2016 - 06/2007
5	Monoclonal AntibodiesIBA 01/2022 - 04/2005
5	polatuzumab vedotinIBA 01/2022 - 06/2015
4	ParaffinIBA 09/2015 - 06/2008
3	carboxyl radical (COO-)IBA 11/2021 - 09/2015
3	GalliumIBA 10/2021 - 01/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 09/2012
3	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 09/2012
3	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 09/2012
3	ibrutinibIBA 01/2021 - 01/2019
3	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 06/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2017
2	venetoclaxIBA 01/2021 - 01/2019
2	AnthracyclinesIBA 01/2021 - 01/2008
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 06/2015
2	Lenalidomide (CC 5013)FDA Link 01/2018 - 01/2017
2	R-CHOP protocolIBA 10/2016 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 01/2010
2	MicroRNAs (MicroRNA)IBA 08/2013 - 06/2011
1	ElementsIBA 01/2022
1	bamlanivimabIBA 01/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	sotrovimabIBA 01/2022
1	cilgavimabIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	tixagevimabIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	NucleotidesIBA 10/2021
1	AntigensIBA 01/2020
1	LigandsIBA 12/2019
1	pinatuzumab vedotinIBA 05/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	ChromatinIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 10/2018
1	1-methyl-4-(1-naphthylvinyl)piperidine (B 120)IBA 01/2018
1	Gemcitabine FDA Link 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 09/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Immunoconjugates (Immunoconjugate)IBA 06/2015
1	Antiviral Agents (Antivirals)IBA 05/2015
1	Bevacizumab (Avastin)FDA Link 08/2014

Therapy/Procedure

33	Therapeutics 12/2022 - 04/2005
25	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
5	Radiotherapy 01/2021 - 09/2012
3	Stem Cell Transplantation 01/2022 - 10/2017
2	Transplantation 10/2020 - 06/2015
2	Immunotherapy 01/2019 - 01/2018
2	Cell Transplantation 06/2015 - 01/2012
1	Radioimmunotherapy 01/2022
1	Precision Medicine 01/2022
1	Contraindications 01/2021
1	Organ Transplantation 01/2020
1	Salvage Therapy 01/2017
1	Treatment Delay 01/2016
1	Hematopoietic Stem Cell Transplantation 06/2015
1	Splenectomy 05/2015
1	Complementary Therapies (Alternative Medicine) 12/2014